Harmonic Discovery
1-10 employees New York, United States
Harmonic Discovery is revolutionizing drug design by focusing on multi-process diseases such as cancer and autoimmunity. Unlike traditional methods targeting a single biological mechanism, their approach embraces the complexity of diseases. They specialize in the human kinome-related therapeutics, leveraging the extensive protein family associated with various diseases. Their platform synthesizes information from mutations, protein structures, and gene expression changes. Their work is grounded in peer-reviewed research, combining expertise in medicinal chemistry, cheminformatics, computational biology, and machine learning. Supported by top investors, they're at the forefront of creating a new generation of precision therapeutics.